All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 137 of 206 pages ‹ First < 135 136 137 138 139 > Last ›
HSL483
Letters to the Editor
The Wall Street Journal 2004 May 9
HSL484
Mathews A.
Invasive Procedure After Medtronic Lobbying Push, The FDA Had Change of Heart: Agency Squelches an Article Raising Doubts on Safety Of Device to Repair Artery Threat of 'Criminal Sanction'
The Wall Street Journal 2004 May 9
HSL324
Harris G.
U.S. Rules Morning-After Pill Can't Be Sold Over the Counter
The New York Times 2004 May 7
HSL325
Willman D.
Panel Wants Top Health Officials Off Drug Payrolls
The Los Angeles Times 2004 May 7
HSL326
Weiss R.
NIH Panel Backs Tighter Limits on Outside Income
The Washington Post 2004 May 7
HSL489
Cancer drug monopoly: SC issues notice
TOI Mumbai 2004 May 7
HSL481
Rabin R.
'We've been bamboozled' about cholesterol risks
Newsday.com 2004 May 6
HSL482
Vedantam S.
Drugmakers Prefer Silence On Test Data
The Washington Post 2004 May 6
HSL479
Bowe C.
Anti-depressant hearings set for this month
Financial Times 2004 May 5
HSL480
Double Dipping at NIH July 5, 2004
The Washington Post 2004 May 5
HSL2400
Helft PR, Ratain MJ, Epstein RA, Siegler M.
Inside information: Financial conflicts of interest for research subjects in early phase clinical trials.
J Natl Cancer Inst 2004 May 5;96:(9):656-61
http://jncicancerspectrum.oxfordjournals.org/cgi/content/full/jnci;96/9/656
HSL323
Goozner M.
Disputing how drug costs are computed: The $800 Million Pill: The Truth Behind the Cost of New Drugs
Philadelphia Inquirer 2004 May 2
HSL127
Mayor S.
Cardiovascular disease threatens developing countries.
BMJ 2004 May 1;328:(7447):1032
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1036
HSL128
Mayor S.
Squeezing academic research into a commercial straitjacket.
BMJ 2004 May 1;328:(7447):1036
http://www.bmj.com/content/328/7447/1036.1
HSL131
Burton B.
AstraZeneca digs in over advertising criticisms.
BMJ 2004 May 1;328:(7447):1035
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1035-a
HSL134
Burton B.
Drug industry to fight New Zealand's move to ban direct to consumer advertising.
BMJ 2004 May 1;328:(7447):1036
http://bmj.bmjjournals.com/cgi/content/full/328/7447/1036-d
HSL322
Bibel B.
Best Consumer Health Books 2003
Library Journal 2004 May 1
HSL1157
Watkins RS, Kimberly J Jr.
What residents don't know about physician-pharmaceutical industry interactions.
Acad Med 2004 May;79:(5):432-7
http://www.academicmedicine.org/cgi/content/full/79/5/432
HSL1169
Sorensen TD, Song J, Westberg SM.
The limitation of good intentions: prescribing medications for the uninsured.
J Health Care Poor Underserved 2004 May;15:(2):152-60
HSL1781
Brieger WR, Osamor PE, Salami KK, Oladepo O, Otusanya SA.
Interactions between patent medicine vendors and customers in urban and rural Nigeria.
Health Policy Plan 2004 May;19:(3):177-82
http://heapol.oxfordjournals.org/cgi/reprint/19/3/177
HSL3588
Sterckx S.
Patents and access to drugs in developing countries: an ethical analysis.
Developing World Bioeth 2004 May;4:(1):58-75
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15086374&query_hl=2&itool=pubmed_docsum
HSL7324
De las Cuevas C, Sanz E.
Do therapeutic indications of antidepressants change from one year to another?
Pharmacoepidemiol Drug Saf 2004 May;13:(5):309-14
http://www3.interscience.wiley.com/cgi-bin/abstract/105556973/ABSTRACT?CRETRY=1&SRETRY=0
HSL9687
Divac N, Jasovic M, Djukic L, Vujnovic M, Babic D, Bajcetic M, Samardzic R.
Benzodiazepines utilization and self-medication as correlates of stress in the population of Serbia.
Pharmacoepidemiol Drug Saf 2004 May;13:(5):315-22
http://www3.interscience.wiley.com/cgi-bin/abstract/107633037/ABSTRACT
HSL9691
Ho MR, Baker JE, Miller AL.
Simvastatin-induced rhabdomyolysis.
Am J Emerg Med 2004 May;22:(3):234-5
http://linkinghub.elsevier.com/retrieve/pii/S0735675704000592
HSL9693
Rapaport MJ.
Follow-up of 1 mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated.
Dermatol Surg 2004 May;30:(5):761-3
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1524-4725.2004.30213.x
HSL9723
Raymond EG, Spruyt A, Bley K, Colm J, Gross S, Robbins LA.
The North Carolina DIAL EC project: increasing access to emergency contraceptive pills by telephone.
Contraception 2004 May;69:(5):367-72
http://linkinghub.elsevier.com/retrieve/pii/S0010782404000502
HSL9847
FDA Reanalyzes Data as Controversy Continues Over Antidepressant Use by Children and Adolescents
Psychiatr Serv 2004 May;55:(5):598-599
http://www.psychservices.psychiatryonline.org/cgi/content/full/55/5/598
HSL20374
Pitts P
FDA decision making
Health Affairs 2004 May;23:(3):287
http://content.healthaffairs.org/content/23/3/287.1.full
HSL321
Web Sparks Debate Over Drug Ads in Europe
iHealthBeat 2004 Apr 30
HSL5475
Mansfield PR.
Clarification and Update for AdWatch on Nexium dialogue
BMJ 2004 Apr 30;328:
http://bmj.bmjjournals.com/cgi/eletters/328/7447/1035-a
HSL320
Kaplan J.
GOP gives green light to trade deal: Speaker Hastert has been sitting on bill for months
The Hill 2004 Apr 28
HSL319
Tierney P.
Novartis Offers Money Back on Blood Pressure Drugs
Reuters 2004 Apr 27
HSL316
Hannan E, Dunn A.
Unease over effects of medication
The Age 2004 Apr 26
HSL145
Charatan F.
Drug company raises US price of AIDS drug five-fold.
BMJ 2004 Apr 24;328:(7446):974
http://bmj.bmjjournals.com/cgi/content/full/328/7446/974-a
HSL147
Tanne JH.
US consumer group names 'dirty dozen' dietary supplements
BMJ 2004 Apr 24;328:(7446):975
http://bmj.bmjjournals.com/cgi/content/full/328/7446/975-c
HSL149
Lenzer J.
New Cochrane policy tightens limits on industry funding.
BMJ 2004 Apr 24;328:(7446):976
http://bmj.bmjjournals.com/cgi/content/full/328/7446/976-a
HSL1420
Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E.
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.
Lancet 2004 Apr 24;363:(9418):1341-5
http://linkinghub.elsevier.com/retrieve/pii/S0140673604160431
HSL310
Depressing News on Depression
The New York Times 2004 Apr 23
HSL311
Dahir M.
Allow imported HIV/AIDS drugs: Abbott Labs' decision to raise by 500 percent the price of the AIDS drug Norvir underscores why the U.S. government must allow cheaper drugs to be imported into this country.
The Washington Blade 2004 Apr 23
HSL312
Laurance J.
Pharmaceutical companies accused of manipulating drug trials for profit
Independent.co.uk 2004 Apr 23
HSL313
Laurance J.
The link between industry, authors and their results
Independent.co.uk 2004 Apr 23
HSL314
Laurance J.
Firms become more aggressive as productivity crisis takes its toll
Independent.co.uk 2004 Apr 23
HSL315
Vedantam S.
Antidepressants Called Unsafe For Children: 4 Medications Singled Out In Analysis of Many Studies
Washington Post 2004 Apr 23
HSL309
Norman J.
Drug firm lobbyists intruded, Grassley says: 'Industry plants' attended several town meetings on a Medicare law in Iowa last week, the senator says.
Register Washington Bureau 2004 Apr 22
HSL307
Ferrie J.
When Good Drugs Go Bad: Adverse pharmaceutical reactions are a major killer, and a B.C. group is fighting to reduce the risk
The Tyee 2004 Apr 21
HSL308
Stewart H.
Aventis goes to court to block Sanofi
The Guardian 2004 Apr 21
HSL305
Study: Doctors Often Pick Costlier Drugs
The Associated Press 2004 Apr 20
HSL306
Younge G.
Gifts used to lure Aids business
The Guardian 2004 Apr 20
HSL9724
Wilson JF.
Cheaper drugs in foreign markets increase the focus on domestic drug prices.
Ann Intern Med 2004 Apr 20;140:(8):677-80
http://www.annals.org/cgi/reprint/140/8/677.pdf
HSL143
Hutchinson MS.
Pharmaceutical companies and medical students: a student's view.
Med J Aust 2004 Apr 19;180:(8):414
http://www.mja.com.au/public/issues/180_08_190404/hut10183_fm.html
HSL151
Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN.
The ethics of pharmaceutical industry relationships with medical students.
Med J Aust 2004 Apr 19;180:(8):411-4
http://www.mja.com.au/public/issues/180_08_190404/rog10715_fm.html
HSL340
Neergaard L
Maker to pull antidepressant off market
The Associated Press 2004 Apr 19
HSL1782
Breen KJ.
The medical profession and the pharmaceutical industry: when will we open our eyes?
Med J Aust 2004 Apr 19;180:(8):409-10
http://www.mja.com.au/public/issues/180_08_190404/bre10055_fm.html
HSL302
MacAfee M.
Health Canada to get clearer picture of prescription drug sales, usage
Canadian Press 2004 Apr 18
HSL303
Vedantam S.
Antidepressant Use in Children Soars Despite Efficacy Doubts
Washington Post 2004 Apr 18
HSL304
Guart A.
New York University Now A 'Meds' School: Doling out antidepressants
The New York Post 2004 Apr 18
HSL9726
't Jong GW, Stricker BH, Sturkenboom MC.
Marketing in the lay media and prescriptions of terbinafine in primary care: Dutch cohort study.
BMJ 2004 Apr 17;328:(7445):931
http://www.bmj.com/cgi/content/full/328/7445/931
HSL5397
Harris G.
Expert Kept From Speaking At Antidepressant Hearing
The New York Times 2004 Apr 16
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9B0CE7D6153BF935A25757C0A9629C8B63
HSL20022
Rayner F
Call for rep scrutiny
Australian Doctor 2004 Apr 1613
HSL301
Woodman R.
British charities call for HRT review
2004 Apr 15
HSL300
McKenzie J.
Drug Company Kickbacks: Pharmaceutical Companies Offer Doctors Free Trips, Gifts for Prescriptions
ABC News 2004 Apr 13
HSL297
Gauthier-villars D.
French Official Wants Government To Stand Neutral in Sanofi's Bid
Dow Jones Newswires 2004 Apr 12
HSL298
Pear R.
Medicare Web Site to Shine Light on Drug Prices
The New York Times 2004 Apr 12
HSL299
Lavioe D.
Drug Company Employees Face Mass Trial
Associated Press Writer 2004 Apr 12
HSL294
Young A.
Healing corrupted by practices of Big Pharma
The Toronto Star 2004 Apr 11
HSL295
Morgan S.
Opening more than the medicine cabinet
Winnipeg Free Press 2004 Apr 11
HSL296
Japsen B.
Costly dose of TV drug ads: `Why on earth' tout $10,000-$20,000-a-year specialized medications?
Chicago Tribune 2004 Apr 11
HSL152
Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL.
Efficacy and safety of antidepressants for children and adolescents.
BMJ 2004 Apr 10;328:(7444):879-83
http://bmj.com/cgi/content/full/328/7444/879
HSL15825
Robotham J.
Drug firms accused of preying on children
The Sydney Morning Herald 2004 Apr 10
http://www.smh.com.au/articles/2004/04/09/1081326929815.html
HSL293
Willman D.
Curbs on Outside Deals at NIH Urged: A draft report by a blue ribbon committee calls for limits and public disclosure on consulting work, but stops short of suggesting a ban.
LA Times 2004 Apr 9
HSL291
Bush, AIDS, Big Pharma
The Nation 2004 Apr 8
HSL292
Dabade G.
High drug prices without rationale: Drug companies influence doctors and impose an unfair drug pricing regime which causes hardship to the poor
Drug Action India 2004 Apr 8
HSL290
Grady D.
Nominal Benefits Seen in Drugs for Alzheimer's Disease
The New York Times 2004 Apr 7
HSL289
Brownlee , S .
Doctors Without Borders: Why you can't trust medical journals anymore
Washington Monthly, 2004 Apr 4
http://www.newamerica.net/publications/articles/2004/doctors_without_borders
HSL317
Hannan E, Dunn A.
Child depression drugs soar
The Age 2004 Apr 4
HSL140
Gulhati CM.
Marketing of medicines in India.
BMJ 2004 Apr 3;328:(7443):778-9
http://bmj.bmjjournals.com/cgi/content/full/328/7443/778
HSL9718
Facing competition on veterinary medicines supply.
Vet Rec. 2004 Apr 3;154:(14):417-8
HSL288
Hoen E.
Generic drugs for fighting AIDS
2004 Apr 2
HSL5293
Butzlaff M, Vollmar HC, Floer B, Koneczny N, Isfort J, Lange S.
Learning with computerized guidelines in general practice: A randomized controlled trial.
Fam Pract 2004 Apr 01;21:(2):183-8
http://fampra.oxfordjournals.org/cgi/content/full/21/2/183
HSL5340
Kaufman R.
The Neurontin Controversy: The Saga of Off-Label Drug Regulation Continues
Legal Electronic Document Archive: Harvard Law School 2004 Apr 1;
http://leda.law.harvard.edu/leda/data/638/Kaufman.html
HSL15096
Lynch M.
Ghost Writing and other Matters
Social Studies of Science 2004 Apr 1;34:147-148
http://sss.sagepub.com/cgi/reprint/34/2/147
HSL15097
Sismondo S.
Pharmaceutical Maneuvers
Social Studies of Science 2004 Apr 1;34:149-159
http://post.queensu.ca/~sismondo/Maneuvers.pdf
HSL15099
Fishman JR.
Manufacturing Desire:: The Commodification of Female Sexual Dysfunction
Social Studies of Science 2004 Apr 1;34:(2):187-218
http://sss.sagepub.com/cgi/content/abstract/34/2/187
HSL15101
Lakoff A.
The Anxieties of Globalization:: Antidepressant Sales and Economic Crisis in Argentina
Social Studies of Science 2004 Apr 1;34:(2):247-269
http://sss.sagepub.com/cgi/content/abstract/34/2/247
HSL15102
Greene JA.
Attention to ‘Details’: Etiquette and the Pharmaceutical Salesman in Postwar American
Social Studies of Science 2004 Apr 1;34:(2):271-292
http://sss.sagepub.com/cgi/content/abstract/34/2/271
HSL19822
Organon and Pfizer First Founding Sponsors of MedEvents 'obgynworld.com' site
CNW Telbec 2004 Apr 1
HSL20365
Capozzi JD, Delsignore JL
Reimbursement incentives to physicians
The Journal of Bone and Joint Surgery 2004 Apr 1;86:(4):876
http://jbjs.org/article.aspx?articleid=26471
HSL138
Marco CA.
Pharmaceutical advertising in emergency departments.
Acad Emerg Med 2004 Apr;11:(4):401-4
http://www.aemj.org/cgi/content/full/11/4/401
HSL1779
Buchkowsky SS, Jewesson PJ.
Industry sponsorship and authorship of clinical trials over 20 years.
Ann Pharmacother 2004 Apr;38:(4):579-85
http://www.theannals.com/cgi/content/full/38/4/579
HSL2123
Munce SE, Robertson EK, Sansom SN, Stewart DE.
Who is portrayed in psychotropic drug advertisements?
J Nerv Ment Dis 2004 Apr;192:(4):284-8
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0022-3018&volume=192&issue=4&spage=284
HSL2398
Lakoff , A.
The anxieties of globalization: antidepressant sales and economic crisis in Argentina
Soc Stud Sci 2004 Apr;34:(2):247-69
HSL2399
Landers SH, AR.
Health care lobbying in the United States
Am J Med 2004 Apr;116:(7):474-7
HSL3691
Brown B, chair for Standing Committee on Health.
Opening the Medicine Cabinet: First Report on Health Aspects of Prescription Drugs.
Ottawa, Canada:: House of Commons 2004 Apr
http://www.parl.gc.ca.
HSL9678
Bertoldi AD, Barros AJ, Hallal PC, Lima RC.
[Drug utilization in adults: prevalence and individuals determinants]
Rev Saude Publica. 2004 Apr;38:(2):228-38
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102004000200012&tlng=en&lng=en&nrm=iso
HSL9695
Fraser E, Stephen C, Bowie WR, Wetzstein M.
Availability and estimates of veterinary antimicrobial use in British Columbia.
Can Vet J 2004 Apr;45:(4):309-11
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15144102
HSL9711
Nordstrom BL, Oh K, Sacks ST, L'Italien GJ.
Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study.
Antivir Ther 2004 Apr;9:(2):187-95
HSL9712
James MJ, Cleland LG.
Applying a research ethics committee approach to a medical practice controversy: the case of the selective COX-2 inhibitor rofecoxib.
J Med Ethics 2004 Apr;30:(2):182-4
http://jme.bmj.com/cgi/content/full/30/2/182
HSL9748
Becker D, Garcia SG, Ellertson C.
Do Mexico City pharmacy workers screen women for health risks when they sell oral contraceptive pills over-the-counter?
Contraception 2004 Apr;69:(4):295-9
http://linkinghub.elsevier.com/retrieve/pii/S0010782403003275
HSL13311
Wagner JL, McCarthy E.
International differences in drug prices.
Annu Rev Public Health 2004 Apr;25:475-95
http://arjournals.annualreviews.org/doi/abs/10.1146/annurev.publhealth.25.101802.123042
HSL18040
Marco CA.
Pharmaceutical advertising in emergency departments.
Acad Emerg Med 2004 Apr;11:(4):401-4
http://www.ncbi.nlm.nih.gov/pubmed/15064217
Page 137 of 206 pages ‹ First < 135 136 137 138 139 > Last ›
